Search results
Bedside Manner Matters
Medscape· 4 hours ago"I've noticed there are certain types of doctors who are very intelligent but don't have that communication connection with patients," said Errol...
The Swiftly Evolving Story of EGFR-Mutated NSCLC Management
MedPage Today· 3 days ago"Understanding mechanisms of resistance may enable the personalization of sequential...
Osteoarthritis Drugs Need Trials With Appropriate Endpoints
Medscape· 3 days agoFor the elusive target of disease-modifying OA drugs (DMOADs), "there have been a lot of...
Lifestyle Changes Still Net Benefits in OA, RA After 2 Years
Medscape· 6 days agoAt the European Alliance of Associations for Rheumatology (EULAR) 2024 Annual Meeting, Carlijn...
6 Things to Do in Your 30s to Improve Your Memory for the Long Haul
Self via Yahoo News· 7 days agoIt’s been shown to reduce your risk of mild cognitive impairment and dementia and boost how well...
Biotechs Race to Develop New Treatments as Global Pancreatic Cancer Market Size Expected to Reach...
Morningstar· 4 days agoPALM BEACH, Fla., June 20, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - Pancreatic cancer is among the most frequently diagnosed and the seventh leading cause of cancer death globally. Pancreatic cancer becomes more common in the Western
Gilead’s Twice-Yearly Lenacapavir Demonstrated 100% Efficacy and Superiority to Daily Truvada® for...
Morningstar· 4 days agoGilead Sciences, Inc. (Nasdaq: GILD) today announced topline results from an interim analysis of its pivotal, Phase 3 PURPOSE 1 trial indicating that the company’s twice-yearly injectable HIV ...
What Is Long COVID, Exactly? A New Universal Definition May Help More People Access Care
Health.com· 6 days ago“Our committee hopes this single definition, crafted with input from across research and patient...
Large-Scale Intensive BP Intervention Proves Sustainable for CVD Prevention
MedPage Today· 6 days agoCommunity-based program reduced events regardless of age, diabetes
Slowing inflammation may boost immunotherapy’s e | Newswise
Newswise· 6 days agoPHILADELPHIA – Adding an anti-inflammatory drug to anti-PD1 checkpoint inhibitor immunotherapy has shown great promise as a new strategy against advanced lung cancer, based on results from a ...